Bottom Line: The U.S. Preventive Services Task Force (USPSTF) recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons at increased risk of HIV acquisition to decrease the risk of acquiring HIV. An estimated 1.2 million persons in the U.S. currently have HIV, and more than 760,000 persons have died of complications related to HIV since the first cases were reported in 1981. Although treatable, HIV is not curable and has significant health consequences. Therefore, effective strategies to prevent HIV are an important public health and clinical priority. The USPSTF routinely makes recommendations about the effectiveness of preventive care services and this recommendation is consistent with its 2019 recommendation on PrEP for the prevention of HIV. For the current recommendation, the USPSTF reviewed additional evidence on new formulations of PrEP.
(doi:10.1001/jama.2023.14461)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Note : More information about the U.S. Preventive Services Task Force, its process, and its recommendations can be found on the newsroom page of its website.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time and all USPSTF articles remain free indefinitely https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.14461?guestAccessKey=9b73114d-93d9-49c8-9339-358cc6b94639&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082223
JAMA